Promising advances in Lyme disease prevention: A closer look at the VLA15 vaccine
Introduction to VLA15: A new hope against Lyme disease A new vaccine, VLA15, is making headlines as it enters the final phase of clinical trials. Developed by Pfizer and Valneva, this vaccine aims to provide a much needed defense against Lyme disease, a prevalent tickborne illness affecting nearly 476,000 Americans annually. Understanding the vaccine’s mechanism […]